Staging System Developed for Revision Rhinoplasty

This article originally appeared here.
Share this content:
Staging System Developed for Revision Rhinoplasty
Staging System Developed for Revision Rhinoplasty

FRIDAY, May 6, 2016 (HealthDay News) -- A PGS staging system, comprising three major components, has been developed for prognosis in revision rhinoplasty, according to a report published online May 5 in JAMA Facial Plastic Surgery.

Regina Rodman, M.D., and Russell Kridel, M.D., from the University of Texas Health Science Center at Houston, present components that could be used to classify patients presenting for revision rhinoplasty.

The authors describe three major components that determine the overall difficulty of revision rhinoplasty surgery, called the PGS system. P represents "problem," which describes the patients' specific anatomic anomaly. G represents "graft" and is based on the number of grafts required. S represents the number of previous "surgical" procedures. An additional component, E, represents patient "expectations," and can be added after the stage of a patient's condition has been ascertained using the PGS classification system.

"This preoperative staging system may help the patient understand the complexity of the repair required and help manage expectations," the authors write. "The PGS system will facilitate exchange of information between surgeons who perform revision rhinoplasty. A standardized evaluation system will allow meaningful comparisons of surgical techniques and evaluations of outcomes of rhinoplasty procedures."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Post-Deployment Screening Has Limited Benefit in U.K. Military

Post-Deployment Screening Has Limited Benefit in U.K. Military

Screening based on tailored advice does not reduce prevalence of disorders or increase help-seeking

Excess BMI Ups Risk of T1DM in Autoantibody-Positive Relatives

Excess BMI Ups Risk of T1DM in Autoantibody-Positive ...

Increased diabetes progression risk occurred at lower cumulative excess BMI index in children <12

Baricitinib Associated With Significant Improvement in RA

Baricitinib Associated With Significant Improvement in RA

Findings versus placebo, adalimumab in patients non-responsive to methotrexate

is free, fast, and customized just for you!

Already a member?

Sign In Now »